These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 29329660)
21. Predicting the need for a replan in oropharyngeal cancer: A radiomic, clinical, and dosimetric model. Chinnery TA; Lang P; Nichols AC; Mattonen SA Med Phys; 2024 May; 51(5):3510-3520. PubMed ID: 38100260 [TBL] [Abstract][Full Text] [Related]
22. Computed Tomography-Based Radiomic Features Could Potentially Predict Microsatellite Instability Status in Stage II Colorectal Cancer: A Preliminary Study. Fan S; Li X; Cui X; Zheng L; Ren X; Ma W; Ye Z Acad Radiol; 2019 Dec; 26(12):1633-1640. PubMed ID: 30929999 [TBL] [Abstract][Full Text] [Related]
23. Radiation dose to the cochlea and its association with sensorineural hearing loss in head and neck cancer-A prospective study. Apoorva KV; Vijendra Shenoy S; Athiyamaan MS; Kabekkodu S; Kshithi K; Zuturu N Am J Otolaryngol; 2023; 44(4):103914. PubMed ID: 37178536 [TBL] [Abstract][Full Text] [Related]
24. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy. Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178 [TBL] [Abstract][Full Text] [Related]
25. CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer. Leger S; Zwanenburg A; Pilz K; Zschaeck S; Zöphel K; Kotzerke J; Schreiber A; Zips D; Krause M; Baumann M; Troost EGC; Richter C; Löck S Radiother Oncol; 2019 Jan; 130():10-17. PubMed ID: 30087056 [TBL] [Abstract][Full Text] [Related]
26. CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. Yang Z; He B; Zhuang X; Gao X; Wang D; Li M; Lin Z; Luo R J Radiat Res; 2019 Jul; 60(4):538-545. PubMed ID: 31111948 [TBL] [Abstract][Full Text] [Related]
27. Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review. Mujica-Mota M; Waissbluth S; Daniel SJ Head Neck; 2013 Nov; 35(11):1662-8. PubMed ID: 23280686 [TBL] [Abstract][Full Text] [Related]
28. Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning. Nazari M; Shiri I; Hajianfar G; Oveisi N; Abdollahi H; Deevband MR; Oveisi M; Zaidi H Radiol Med; 2020 Aug; 125(8):754-762. PubMed ID: 32193870 [TBL] [Abstract][Full Text] [Related]
29. Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer. Schuette A; Lander DP; Kallogjeri D; Collopy C; Goddu S; Wildes TM; Daly M; Piccirillo JF JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):106-112. PubMed ID: 31750863 [TBL] [Abstract][Full Text] [Related]
30. Radiomics-based prediction of recurrence for head and neck cancer patients using data imbalanced correction. Oka H; Kawahara D; Murakami Y Comput Biol Med; 2024 Sep; 180():108879. PubMed ID: 39067154 [TBL] [Abstract][Full Text] [Related]
32. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma. Chang C; Sun X; Wang G; Yu H; Zhao W; Ge Y; Duan S; Qian X; Wang R; Lei B; Wang L; Liu L; Ruan M; Yan H; Liu C; Chen J; Xie W Front Oncol; 2021; 11():603882. PubMed ID: 33738250 [TBL] [Abstract][Full Text] [Related]
33. Sensorineural hearing loss after radiotherapy for head and neck tumors: a prospective study of the effect of radiation. Yilmaz YF; Aytas FI; Akdogan O; Sari K; Savas ZG; Titiz A; Tumoz M; Unal A Otol Neurotol; 2008 Jun; 29(4):461-3. PubMed ID: 18520582 [TBL] [Abstract][Full Text] [Related]
34. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885 [TBL] [Abstract][Full Text] [Related]
35. Machine learning-based multiparametric MRI radiomics for predicting the aggressiveness of papillary thyroid carcinoma. Wang H; Song B; Ye N; Ren J; Sun X; Dai Z; Zhang Y; Chen BT Eur J Radiol; 2020 Jan; 122():108755. PubMed ID: 31783344 [TBL] [Abstract][Full Text] [Related]
36. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer. Larue RTHM; Klaassen R; Jochems A; Leijenaar RTH; Hulshof MCCM; van Berge Henegouwen MI; Schreurs WMJ; Sosef MN; van Elmpt W; van Laarhoven HWM; Lambin P Acta Oncol; 2018 Nov; 57(11):1475-1481. PubMed ID: 30067421 [TBL] [Abstract][Full Text] [Related]
37. Clear cell renal cell carcinoma: Machine learning-based computed tomography radiomics analysis for the prediction of WHO/ISUP grade. Shu J; Wen D; Xi Y; Xia Y; Cai Z; Xu W; Meng X; Liu B; Yin H Eur J Radiol; 2019 Dec; 121():108738. PubMed ID: 31756634 [TBL] [Abstract][Full Text] [Related]
38. Machine Learning Based Radiomic HPV Phenotyping of Oropharyngeal SCC: A Feasibility Study Using MRI. Sohn B; Choi YS; Ahn SS; Kim H; Han K; Lee SK; Kim J Laryngoscope; 2021 Mar; 131(3):E851-E856. PubMed ID: 33070337 [TBL] [Abstract][Full Text] [Related]
39. Hearing Loss After Cisplatin-based Chemoradiotherapy for Locally Advanced Head and Neck Cancer: A Prospective Single-institution Study. Musio D; DE Vincentiis M; D'Urso P; Musacchio A; Maiuri V; Zaccaro L; Ralli M; Marchetti C; Turchetta R; Tombolini V; DE Felice F Anticancer Res; 2022 Jun; 42(6):3003-3009. PubMed ID: 35641273 [TBL] [Abstract][Full Text] [Related]
40. Predicting the hearing outcome in sudden sensorineural hearing loss via machine learning models. Bing D; Ying J; Miao J; Lan L; Wang D; Zhao L; Yin Z; Yu L; Guan J; Wang Q Clin Otolaryngol; 2018 Jun; 43(3):868-874. PubMed ID: 29356346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]